Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;16(3):255-257.
doi: 10.1177/1534735415622013. Epub 2015 Dec 16.

B-Cell Disorders and Curcumin

Affiliations

B-Cell Disorders and Curcumin

Terry Golombick et al. Integr Cancer Ther. 2017 Sep.

Abstract

Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.

Keywords: curcumin; integrative medicine; monoclonal gammopathy of undetermined significance; smoldering myeloma; stage 0/1 chronic lymphocytic leukemia.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

Cited by

References

    1. Aggarwal BB, Kumar A, Aggarwal MS, Shisodia S. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Bagchi D, Preuss HG. eds. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton, FL: CRC Press; 2005:349-387.
    1. Shanmugam MK, Rane G, Kanchi MM, et al. The multifaceted role of curcumin in cancer prevention and treatment. Molecules. 2015;20:2728-2769. - PMC - PubMed
    1. Beutler E, Lichtman MA, Coller BS, Kipps TJ. Williams Hematology. 5th ed. New York, NY: McGraw-Hill; 1995.
    1. Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412-5417. - PMC - PubMed
    1. Korde N, Kristinsson SY, Landgren O. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Blood. 2011;117:5573-5581. - PMC - PubMed

LinkOut - more resources